1 – 9 of 9
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Pituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis : analysis of the KIMS database
(
- Contribution to journal › Article
- 2019
-
Mark
Change in baseline characteristics over 20 years of adults with growth hormone (GH) deficiency on GH replacement therapy
(
- Contribution to journal › Article
- 2018
-
Mark
Relative risks of contributing factors to morbidity and mortality in adults with craniopharyngioma on growth hormone replacement
(
- Contribution to journal › Article
- 2017
-
Mark
Radiotherapy, especially at young age, increases the risk for de novo brain tumors in patients treated for pituitary/sellar lesions
(
- Contribution to journal › Article
- 2013
-
Mark
Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
(
- Contribution to journal › Article
- 2012
-
Mark
Incidence of Diabetes Mellitus and Evolution of Glucose Parameters in Growth Hormone-Deficient Subjects During Growth Hormone Replacement Therapy A long-term observational study
(
- Contribution to journal › Article
- 2011
-
Mark
Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
(
- Contribution to journal › Article
- 2010
-
Mark
The prevalence of diabetes mellitus in 6389 adult patients with treatment naive adult-onset growth hormone deficiency (AO-GHD) before GH replacement. A KIMS analysis
(
- Contribution to journal › Published meeting abstract
-
Mark
Metabolic syndrome (MetS) in 2610 growth hormone deficient (GHD) patients before GH treatment start: A KIMS (Pfizer International Metabolic Database) analysis
(
- Contribution to journal › Published meeting abstract